Barrie Peck The Breast Cancer Now Toby Robins Research Centre, Division of Breast Cancer The Institute of Cancer Research Biography Publications Institution JoVE Articles Barrie Peck has not added a biography. If you are Barrie Peck and would like to personalize this page please email our Author Liaison for assistance. Publications Three-dimensional Modelling Identifies Novel Genetic Dependencies Associated with Breast Cancer Progression in the Isogenic MCF10 Model The Journal of Pathology. Nov, 2016 | Pubmed ID: 27512948 Inhibition of Fatty Acid Desaturation is Detrimental to Cancer Cell Survival in Metabolically Compromised Environments Cancer & Metabolism. 2016 | Pubmed ID: 27042297 Lipid Desaturation - the Next Step in Targeting Lipogenesis in Cancer? The FEBS Journal. Aug, 2016 | Pubmed ID: 26881388 Acetyl-CoA Synthetase 2 Promotes Acetate Utilization and Maintains Cancer Cell Growth Under Metabolic Stress Cancer Cell. Jan, 2015 | Pubmed ID: 25584894 Fatty Acid Uptake and Lipid Storage Induced by HIF-1α Contribute to Cell Growth and Survival After Hypoxia-reoxygenation Cell Reports. Oct, 2014 | Pubmed ID: 25263561 Cholesteryl Esters: Fueling the Fury of Prostate Cancer Cell Metabolism. Mar, 2014 | Pubmed ID: 24606894 Sterol Regulatory Element Binding Protein-dependent Regulation of Lipid Synthesis Supports Cell Survival and Tumor Growth Cancer & Metabolism. Jan, 2013 | Pubmed ID: 24280005 Hooked on Fat: the Role of Lipid Synthesis in Cancer Metabolism and Tumour Development Disease Models & Mechanisms. Nov, 2013 | Pubmed ID: 24203995 Antagonism Between FOXO and MYC Regulates Cellular Powerhouse Frontiers in Oncology. 2013 | Pubmed ID: 23630664 A Role for the Cancer-associated MiR-106b~25 Cluster in Neuronal Stem Cells Aging. Apr, 2011 | Pubmed ID: 21483041 SIRT Inhibitors Induce Cell Death and P53 Acetylation Through Targeting Both SIRT1 and SIRT2 Molecular Cancer Therapeutics. Apr, 2010 | Pubmed ID: 20371709 FOXM1 Confers Acquired Cisplatin Resistance in Breast Cancer Cells Molecular Cancer Research : MCR. Jan, 2010 | Pubmed ID: 20068070 FoxM1 is a Downstream Target and Marker of HER2 Overexpression in Breast Cancer International Journal of Oncology. Jul, 2009 | Pubmed ID: 19513552 Gefitinib (Iressa) Represses FOXM1 Expression Via FOXO3a in Breast Cancer Molecular Cancer Therapeutics. Mar, 2009 | Pubmed ID: 19276163 利用功能基因组筛选识别在肿瘤细胞球体培养潜在的新药物靶标 Eamonn Morrison1,2, Patty Wai1,2, Andri Leonidou1,2, Philip Bland1,2, Saira Khalique1,2, Gillian Farnie3, Frances Daley1, Barrie Peck1,2, Rachael Natrajan1,2 1The Breast Cancer Now Toby Robins Research Centre, Division of Breast Cancer, The Institute of Cancer Research, 2Division of Molecular Pathology, The Institute of Cancer Research, 3Institute of Cancer Sciences, University of Manchester Cancer Research
利用功能基因组筛选识别在肿瘤细胞球体培养潜在的新药物靶标 Eamonn Morrison1,2, Patty Wai1,2, Andri Leonidou1,2, Philip Bland1,2, Saira Khalique1,2, Gillian Farnie3, Frances Daley1, Barrie Peck1,2, Rachael Natrajan1,2 1The Breast Cancer Now Toby Robins Research Centre, Division of Breast Cancer, The Institute of Cancer Research, 2Division of Molecular Pathology, The Institute of Cancer Research, 3Institute of Cancer Sciences, University of Manchester Cancer Research
